SLC6A8 corrector 1 is an orally active and brain-penetrant mutant SLC6A8 variant corrector. SLC6A8 corrector 1 can be used for the study of creatine transporter deficiency (CTD) [1].
In Vivo, SLC6A8 corrector 1 (compound 6; 30 mg/kg; oral gavage) increases brain creatine levels in heterozygous female mice[1].
References:
[1]. Lara N Gechijian, et al. Novel Corrector for Variants of SLC6A8: A Therapeutic Opportunity for Creatine Transporter Deficiency. ACS Chem Biol. 2024 Oct 17.
In Vivo, SLC6A8 corrector 1 (compound 6; 30 mg/kg; oral gavage) increases brain creatine levels in heterozygous female mice[1].
References:
[1]. Lara N Gechijian, et al. Novel Corrector for Variants of SLC6A8: A Therapeutic Opportunity for Creatine Transporter Deficiency. ACS Chem Biol. 2024 Oct 17.
















